Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical ImagingCT MRI Xray

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2076880

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2076880

MRI Systems Market by Architecture, Design, Field Strength, Application, End User, and Procedure Volume - Global Forecast to 2031

PUBLISHED:
PAGES: 241 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The MRI systems market is shifting in terms of design and features, with helium-free and helium-light MRI technologies emerging as a significant growth driver. This development is largely influenced by increasing operational costs, helium supply instability, and the healthcare sector's growing focus on sustainability.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsField Strength, Architecture, Design, Application, End User, and Region
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

Conventional MRI systems typically require over 1,000 liters of helium to cool superconducting magnets. However, global helium shortages-such as the Helium Shortage 4.0 reported by Gasworld-have led to price increases of up to 250%, disrupting imaging operations and increasing maintenance costs. Such challenges are particularly pressing for mid-sized hospitals and outpatient facilities with constrained budgets. In response, manufacturers like Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), and Shanghai United Imaging Healthcare Co., Ltd. (China) have launched MRI systems that require significantly less helium or are completely sealed.

MRI Systems Market - IMG1

These innovations reduce the total cost of ownership and support environmental goals in terms of sustainability and zero carbon emissions.

The global MRI systems market is projected to reach USD 9.68 billion by 2031, growing from USD 6.88 billion in 2026 at a CAGR of 7.0% from 2026 to 2031.

The market's growth can be attributed to an increase in disease burden, specifically for neurological and musculoskeletal conditions, which is expected to increase in the coming years. Additionally, an increase in the aging population, with the rising prevalence of chronic diseases such as cancer, is anticipated to increase the need for MRI systems across the globe. All these factors, on a broader level, will help to grow the market for MRI systems.

By field strength, the high & very high field segment dominated the MRI systems market in 2025.

The MRI systems market is categorized, by field strength, into low-to-mid-field MRI systems, high and very high field MRI systems, and ultra-high-field MRI systems. High and very high field MRI systems are known for their superior signal-to-noise ratio (SNR), which enhances clinical utility significantly. These systems are not only instrumental in imaging the brain, musculoskeletal structures, and vascular systems but also excel in specialized applications within psychiatry, neurology, biomedical research, and the early identification of conditions such as multiple sclerosis. The integration of MRI with complementary modalities such as PET and ultrasound further optimizes operational throughput and decreases helium usage while also delivering faster scan times and enhanced image resolution. High-field MRI systems, specifically those operating at 1.5T and 3T, are favored over low-field systems (below 1T) due to their markedly superior image quality, reduced acquisition times, and extensive range of clinical applications. The elevated SNR in high-field systems translates to clearer, more detailed imaging essential for diagnosing complex conditions such as neurological disorders, musculoskeletal injuries, and cardiovascular abnormalities. The rapid scan capabilities not only improve patient throughput but also enhance operational efficiency within healthcare facilities. Collectively, these factors have driven the growing adoption of high-field MRI systems within the market.

By architecture, the closed MRI systems segment accounted for the largest share of the market in 2025.

A closed MRI scanner utilizes a small cylindrical chamber to produce highly detailed images of the body's structure. Most high-field superconducting magnetic resonance imaging scanners are designed in a closed format. Due to their higher efficiency, superior image quality, and increased throughput-all resulting from greater magnetic field strengths-closed MRI systems are considered the industry standard. In contrast to open MRI systems, which may require up to four or five scans for a comparable evaluation, closed MRI systems typically complete the scanning process in just one or two scans. This efficiency not only shortens examination times but also enhances the clinical utility of procedures and therapies. Closed MRI offers faster scan times, which helps reduce motion artifacts and improves patient throughput, making it particularly suitable for high-volume hospitals and diagnostic centers. Additionally, it supports advanced imaging techniques such as functional MRI (fMRI), diffusion-weighted imaging (DWI), and cardiac MRI, all of which rely on high-field strength for precision.

By design, the fixed/stationary MRI systems segment accounted for the largest share in 2025.

By design, the MRI systems market is divided into fixed/stationary MRI systems and portable MRI systems. Fixed MRI systems are generally preferred over portable ones for several reasons. They offer superior image quality, the ability to conduct full-body scans, improved workflow efficiency, and better long-term cost-effectiveness. Typically, fixed MRI units operate at a magnetic field. Another significant advantage of fixed MRI systems is their capability for full-body imaging, which further fuels market growth.

By application, the brain & neurological MRI segment is expected to register the highest growth rate during the forecast period.

By application, the MRI systems market is segmented into brain & neurological MRI, spine & musculoskeletal MRI, pelvic & abdominal MRI, vascular MRI, breast MRI, cardiac MRI, pediatric MRI, and other applications. The brain & neurological MRI segment of the MRI systems segment is expected to register the highest growth rate during the forecast period. Key drivers contributing to the rapid growth of this segment include the integration of sophisticated AI technologies as well as the increasing adoption of innovative devices that enable accurate targeting of internal organs, thereby facilitating real-time imaging capabilities.

By end user, the hospitals segment accounted for the largest share of the market in 2025.

By end user, the global MRI systems market is categorized into hospitals, diagnostic imaging centers, and other categories. In 2025, the hospitals segment accounted for the largest market share. This dominance is primarily due to the increased use of advanced MRI systems in hospitals, which enhance accurate diagnosis and raise awareness of the importance of early detection. Additionally, factors such as product launches, the growing adoption of advanced systems with improved features that support patient care, and a rising number of imaging procedures conducted in hospitals are also driving the growth of the market. As the demand for rapid and precise diagnoses of various medical conditions grows, many hospitals are prioritizing the installation of advanced MRI systems. Large government hospitals with dedicated imaging units have been early adopters of these technologies, while private hospitals are increasingly embracing advanced imaging solutions over time. The trend towards modernizing imaging workflows has further driven the adoption of MRI systems in hospitals.

Asia Pacific is expected to exhibit the highest growth rate in the MRI systems market.

The MRI systems market spans five primary regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Notably, the Asia Pacific region houses a significant number of MRI systems manufacturers that deliver a comprehensive range of MRI modalities equipped with advanced technological features, all while maintaining competitive pricing. End users, particularly in healthcare institutions, are increasingly facing budget constraints exacerbated by recent tariff sanctions; this has prompted a shift towards more cost-effective MRI solutions offered by Chinese manufacturers. The region's manufacturing landscape benefits from low labor costs and abundant resources, facilitating efficient production processes for MRI systems. These dynamics position the Asia Pacific market to experience the highest growth rate within the global landscape, driven by both increased local demand and the strategic pricing of offerings.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 - 30%; Tier 2 - 40%; and Tier 3 - 30%
  • By Designation: Directors - 10%; Managers - 30%; and Others - 60%
  • By Region: Asia Pacific - 45%; Europe - 22%; North America - 22%; RoW - 11%

The key players profiled in the MRI systems market include Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), Canon Inc. (Japan), Fonar Corporation (US), Esaote S.p.A (Italy), Shanghai United Imaging Healthcare Co., Ltd (China), Aspect Imaging Ltd. (US), and Time Medical Holding (Hong Kong).

Research Coverage

The research report examines the MRI systems market field strength, architecture, design, application, end user, and region. This research covers factors that are driving market expansion, analyzes prospects and parameters faced by industries in the present time, and provides specifics on the competitive landscape, considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions and micro-market analysis

Reasons to Buy the Report

The report will provide market leaders and new entrants with valuable information regarding the revenue estimates for the overall MRI systems market and its subsegments. It will help stakeholders understand the competitive landscape, allowing them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into the market dynamics, including key drivers, restraints, challenges, and opportunities.

This report provides insightful data on the following pointers:

  • Analysis of key drivers (Public-private partnerships to scale diagnostic imaging landscape, integration of iMRI into surgery to catalyze growth of MRI systems market, growing prevalence of MSDs and increasing geriatric population to increase demand), restraints (Complex operation and maintenance of MRI systems, global shortage of helium), opportunities (Emergence of helium-free MRI systems, expansion of pediatric MRI use cases, AI integration with MRI technology for process optimization), challenges (Limited capital budgets, dearth of trained and skilled professionals)
  • Market Penetration: In-depth coverage of product portfolios offered by the top players in the MRI systems market
  • Product Development/Innovation: In-depth coverage of product portfolios offered by the top players in the MRI systems market
  • Market Development: Insightful data on profitable developing areas
  • Market Diversification: Details about recent developments and advancements in the MRI systems market
  • Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors
Show more
Product Code: MD 3220

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 RESEARCH LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN MRI SYSTEMS MARKET
  • 2.4 HIGH GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 MRI SYSTEMS MARKET OVERVIEW
  • 3.2 ASIA PACIFIC MRI SYSTEMS MARKET, BY END USER AND COUNTRY
  • 3.3 MRI SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Public-private partnerships to scale diagnostic imaging landscape
      • 4.2.1.2 Growing prevalence of MSDs and increasing geriatric population
      • 4.2.1.3 Integration of iMRI into surgery
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Complex operation and maintenance of MRI systems
      • 4.2.2.2 Global helium shortage
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Emergence of helium-free MRI systems
      • 4.2.3.2 Expansion of pediatric MRI use cases
      • 4.2.3.3 AI integration with MRI technology for process optimization
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Limited capital budgets
      • 4.2.4.2 Dearth of trained and skilled professionals
  • 4.3 UNMET NEEDS
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MRI SYSTEMS MARKET

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 BARGAINING POWER OF BUYERS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF NEW ENTRANTS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN DIAGNOSTIC IMAGING INDUSTRY
  • 5.3 SUPPLY CHAIN ANALYSIS
    • 5.3.1 PROMINENT COMPANIES
    • 5.3.2 SMALL & MEDIUM-SIZED ENTERPRISES
    • 5.3.3 DISTRIBUTION/DISTRIBUTOR
    • 5.3.4 END USERS
  • 5.4 VALUE CHAIN ANALYSIS
    • 5.4.1 RESEARCH & PRODUCT DEVELOPMENT
    • 5.4.2 RAW MATERIAL PROCUREMENT
    • 5.4.3 MANUFACTURING
    • 5.4.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 PRICING ANALYSIS
    • 5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025
    • 5.6.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT DATA (HS CODE 901813)
    • 5.7.2 EXPORT DATA (HS CODE 901813)
  • 5.8 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.10 INVESTMENT AND FUNDING SCENARIO
  • 5.11 CASE STUDY ANALYSIS
  • 5.12 IMPACT OF 2025 US TARIFF - MRI SYSTEMS MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 KEY TARIFF RATES
    • 5.12.4 PRICE IMPACT ANALYSIS
    • 5.12.5 IMPACT ON COUNTRIES/REGIONS
      • 5.12.5.1 US
      • 5.12.5.2 Europe
      • 5.12.5.3 Asia Pacific
    • 5.12.6 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 ARTIFICIAL INTELLIGENCE-DRIVEN IMAGE RECONSTRUCTION AND DIAGNOSTIC ASSISTANCE
    • 6.1.2 ULTRA-LOW-FIELD AND PORTABLE MRI PLATFORMS
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) AND HEALTH INFORMATION SYSTEM INTEGRATION
    • 6.2.2 SIMULTANEOUS MULTI-SLICE AND ADVANCED PARALLEL IMAGING ACCELERATION
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 MRI-COMPATIBLE INTERVENTIONAL AND SURGICAL NAVIGATION TECHNOLOGIES
  • 6.4 PATENT ANALYSIS
  • 6.5 IMPACT OF AI ON MRI SYSTEMS MARKET
    • 6.5.1 TOP USE CASES AND MARKET POTENTIAL
    • 6.5.2 KEY COMPANIES IMPLEMENTING AI
    • 6.5.3 BEST PRACTICES IN MRI SYSTEMS MARKET
    • 6.5.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
    • 6.5.5 CLIENTS' READINESS TO ADOPT AI IN MRI SYSTEMS
  • 6.6 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
  • 6.7 REGULATORY LANDSCAPE
    • 6.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.7.2 REGULATIONS, BY REGION
      • 6.7.2.1 North America
        • 6.7.2.1.1 US
        • 6.7.2.1.2 Canada
      • 6.7.2.2 Europe
      • 6.7.2.3 Asia Pacific
        • 6.7.2.3.1 Japan
        • 6.7.2.3.2 China
        • 6.7.2.3.3 India
  • 6.8 REIMBURSEMENT SCENARIO ANALYSIS
    • 6.8.1 RELEVANT REIMBURSEMENT CODE, BY COUNTRY
    • 6.8.2 REIMBURSEMENT TRENDS, BY REGION, 2023-2025
      • 6.8.2.1 North America
      • 6.8.2.2 Europe
      • 6.8.2.3 Asia Pacific
      • 6.8.2.4 Latin America
      • 6.8.2.5 Middle East & Africa

7 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

  • 7.1 DECISION-MAKING PROCESS
  • 7.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
    • 7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 7.2.2 BUYING CRITERIA
  • 7.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • 7.4 UNMET NEEDS OF VARIOUS END-USE INDUSTRIES
  • 7.5 MARKET PROFITABILITY

8 MRI SYSTEMS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 BRAIN & NEUROLOGICAL MRI
    • 8.2.1 NEW THERAPIES AND GUIDELINES TO ENHANCE DEMAND FOR MRI SYSTEMS
  • 8.3 SPINE & MUSCULOSKELETAL MRI
    • 8.3.1 GROWING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE MARKET
  • 8.4 VASCULAR MRI
    • 8.4.1 USE OF VASCULAR MRI AS ALTERNATIVE TO CT TO SUPPORT MARKET GROWTH
  • 8.5 PELVIC & ABDOMINAL MRI
    • 8.5.1 NEED FOR DETECTING PROSTATE AND CERVICAL CANCERS TO PROPEL MARKET
  • 8.6 BREAST MRI
    • 8.6.1 GROWING AWARENESS OF EARLY CANCER SCREENING TO DRIVE MARKET GROWTH
  • 8.7 CARDIAC MRI
    • 8.7.1 UPDATED MEDICAL GUIDELINES FOR CARDIAC THERAPY PLANNING TO DRIVE MARKET GROWTH
  • 8.8 PEDIATRIC MRI
    • 8.8.1 NEED FOR EFFICIENT DIAGNOSTIC ACCURACY AND EARLY DETECTION TO PROMOTE USE OF PEDIATRIC MRI
  • 8.9 OTHER APPLICATIONS

9 MRI SYSTEMS MARKET, BY ARCHITECTURE

  • 9.1 INTRODUCTION
  • 9.2 CLOSED MRI SYSTEMS
    • 9.2.1 STANDARD BORE MRI SYSTEMS
      • 9.2.1.1 High accuracy and sensitivity of systems to propel market
    • 9.2.2 WIDE-BORE MRI SYSTEMS
      • 9.2.2.1 High-quality images and improved patient comfort to drive market
  • 9.3 OPEN MRI SYSTEMS
    • 9.3.1 USE FOR CHILDREN AND OBESE PATIENTS TO DRIVE MARKET

10 MRI SYSTEMS MARKET, BY DESIGN

  • 10.1 INTRODUCTION
  • 10.2 FIXED/STATIONARY MRI SYSTEMS
    • 10.2.1 FLOOR-FIXED MRI SYSTEMS
      • 10.2.1.1 High flexibility and low initial installation costs to drive demand
    • 10.2.2 CEILING-FIXED MRI SYSTEMS
      • 10.2.2.1 Need for MRI systems with high stability and more space to drive market
  • 10.3 PORTABLE MRI SYSTEMS
    • 10.3.1 PROTOCOLIZED ADOPTION OF PORTABLE MRI SYSTEMS TO DRIVE MARKET GROWTH

11 MRI SYSTEMS MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 HOSPITALS
    • 11.2.1 UPDATES IN DIAGNOSTIC IMAGING GUIDELINES TO PROPEL MARKET GROWTH
  • 11.3 DIAGNOSTIC IMAGING CENTERS
    • 11.3.1 INCREASED PRIVATE IMAGING CENTERS AND SHIFT TOWARD OUTPATIENT FACILITIES TO DRIVE MARKET GROWTH
  • 11.4 OTHER END USERS

12 MRI SYSTEMS MARKET, BY FIELD STRENGTH

  • 12.1 INTRODUCTION
  • 12.2 HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS
    • 12.2.1 1.5T
      • 12.2.1.1 Rising use of 1.5T MRI systems for routine examinations to propel market
    • 12.2.2 3T
      • 12.2.2.1 Strong gradient profile and ease of use to drive market growth
  • 12.3 LOW-TO-MID-FIELD MRI SYSTEMS
    • 12.3.1 INCREASING NEED FOR LUNG AND CARDIAC IMAGING TO DRIVE MARKET GROWTH
  • 12.4 ULTRA-HIGH-FIELD MRI SYSTEMS
    • 12.4.1 RISING INNOVATION AND DEEP RESEARCH TO DRIVE MARKET GROWTH

13 MRI SYSTEMS MARKET, BY REGION

  • 13.1 INTRODUCTION
  • 13.2 NORTH AMERICA
    • 13.2.1 US
      • 13.2.1.1 Increased diagnostic imaging utilization and strategic reimbursement reforms to drive market growth
    • 13.2.2 CANADA
      • 13.2.2.1 Progressive government policies and growing pulse of diagnostic imaging to spur market
  • 13.3 EUROPE
    • 13.3.1 GERMANY
      • 13.3.1.1 Digital push in healthcare access and shift toward outpatient/clinic settings to drive market growth
    • 13.3.2 UK
      • 13.3.2.1 Strong policy push for community diagnostic centers and capacity expansion to drive market growth
    • 13.3.3 FRANCE
      • 13.3.3.1 Increasing patient population and reforms in MRI coverage policies to boost growth
    • 13.3.4 ITALY
      • 13.3.4.1 EU-funded hospital upgrades to increase capital expenditure ability
    • 13.3.5 SPAIN
      • 13.3.5.1 Strategic policy reforms and increased MRI scans from private hospital chains to grow market
    • 13.3.6 REST OF EUROPE
  • 13.4 ASIA PACIFIC
    • 13.4.1 JAPAN
      • 13.4.1.1 Nationwide diagnostic imaging coverage plans and supportive government reimbursement policies to boost growth
    • 13.4.2 CHINA
      • 13.4.2.1 Foreign collaborations and strong demand from public healthcare facilities to drive market growth
    • 13.4.3 INDIA
      • 13.4.3.1 Strong public-private partnerships to propel market
    • 13.4.4 AUSTRALIA
      • 13.4.4.1 New research initiatives and policy enhancements to promote growth
    • 13.4.5 SOUTH KOREA
      • 13.4.5.1 Supportive government policies to promote growth
    • 13.4.6 REST OF ASIA PACIFIC
  • 13.5 LATIN AMERICA
    • 13.5.1 BRAZIL
      • 13.5.1.1 Increasing disease burden and growing adoption of healthcare insurance to drive market
    • 13.5.2 MEXICO
      • 13.5.2.1 Industry partnerships to drive market growth
    • 13.5.3 REST OF LATIN AMERICA
  • 13.6 MIDDLE EAST & AFRICA
    • 13.6.1 GCC COUNTRIES
      • 13.6.1.1 Favorable government initiatives to contribute to market growth
    • 13.6.2 REST OF MIDDLE EAST & AFRICA
      • 13.6.2.1 Increased adoption of MRI systems to contribute to growth

14 COMPETITIVE LANDSCAPE

  • 14.1 INTRODUCTION
  • 14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023-2026
    • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MRI SYSTEMS MARKET
  • 14.3 REVENUE ANALYSIS, 2021-2025
  • 14.4 MARKET SHARE ANALYSIS, 2025
    • 14.4.1 MARKET RANKING OF KEY PLAYERS, 2025
  • 14.5 COMPANY VALUATION AND FINANCIAL METRICS
    • 14.5.1 FINANCIAL METRICS
    • 14.5.2 COMPANY VALUATION
  • 14.6 BRAND/PRODUCT COMPARISON
  • 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 14.7.1 STARS
    • 14.7.2 EMERGING LEADERS
    • 14.7.3 PERVASIVE PLAYERS
    • 14.7.4 PARTICIPANTS
    • 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 14.7.5.1 Company footprint
      • 14.7.5.2 Region footprint
      • 14.7.5.3 Field strength footprint
      • 14.7.5.4 Application footprint
      • 14.7.5.5 End user footprint
  • 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 14.8.1 PROGRESSIVE COMPANIES
    • 14.8.2 RESPONSIVE COMPANIES
    • 14.8.3 DYNAMIC COMPANIES
    • 14.8.4 STARTING BLOCKS
    • 14.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025
      • 14.8.5.1 Detailed list of key startups/SMEs
      • 14.8.5.2 Competitive benchmarking of key startups/SMEs
  • 14.9 COMPETITIVE SCENARIO
    • 14.9.1 PRODUCT LAUNCHES
    • 14.9.2 DEALS
    • 14.9.3 EXPANSIONS

15 COMPANY PROFILES

  • 15.1 KEY PLAYERS
    • 15.1.1 SIEMENS HEALTHINEERS
      • 15.1.1.1 Business overview
      • 15.1.1.2 Products offered
      • 15.1.1.3 Recent developments
        • 15.1.1.3.1 Product launches
        • 15.1.1.3.2 Deals
        • 15.1.1.3.3 Expansions
      • 15.1.1.4 MnM view
        • 15.1.1.4.1 Right to win
        • 15.1.1.4.2 Strategic choices
        • 15.1.1.4.3 Weaknesses & competitive threats
    • 15.1.2 KONINKLIJKE PHILIPS N.V.
      • 15.1.2.1 Business overview
      • 15.1.2.2 Products offered
      • 15.1.2.3 Recent developments
        • 15.1.2.3.1 Product launches
        • 15.1.2.3.2 Deals
        • 15.1.2.3.3 Expansions
      • 15.1.2.4 MnM view
        • 15.1.2.4.1 Right to win
        • 15.1.2.4.2 Strategic choices
        • 15.1.2.4.3 Weaknesses and competitive threats
    • 15.1.3 GE HEALTHCARE
      • 15.1.3.1 Business overview
      • 15.1.3.2 Products offered
      • 15.1.3.3 Recent developments
        • 15.1.3.3.1 Product launches
        • 15.1.3.3.2 Deals
        • 15.1.3.3.3 Expansions
      • 15.1.3.4 MnM view
        • 15.1.3.4.1 Right to win
        • 15.1.3.4.2 Strategic choices
        • 15.1.3.4.3 Weaknesses & competitive threats
    • 15.1.4 CANON MEDICAL SYSTEM
      • 15.1.4.1 Business overview
      • 15.1.4.2 Products offered
      • 15.1.4.3 Recent developments
        • 15.1.4.3.1 Product launches
        • 15.1.4.3.2 Deals
      • 15.1.4.4 MnM view
        • 15.1.4.4.1 Right to win
        • 15.1.4.4.2 Strategic choices
        • 15.1.4.4.3 Weaknesses & competitive threats
    • 15.1.5 FUJIFILM CORPORATION
      • 15.1.5.1 Business overview
      • 15.1.5.2 Products offered
      • 15.1.5.3 Recent developments
        • 15.1.5.3.1 Product launches
        • 15.1.5.3.2 Deals
      • 15.1.5.4 MnM view
        • 15.1.5.4.1 Right to win
        • 15.1.5.4.2 Strategic choices
        • 15.1.5.4.3 Weaknesses & competitive threats
    • 15.1.6 FONAR CORPORATION
      • 15.1.6.1 Business overview
      • 15.1.6.2 Products offered
      • 15.1.6.3 Recent developments
        • 15.1.6.3.1 Deals
    • 15.1.7 ESAOTE S.P.A
      • 15.1.7.1 Business overview
      • 15.1.7.2 Products offered
      • 15.1.7.3 Recent developments
        • 15.1.7.3.1 Product launches
        • 15.1.7.3.2 Deals
    • 15.1.8 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
      • 15.1.8.1 Business overview
      • 15.1.8.2 Products offered
      • 15.1.8.3 Recent developments
        • 15.1.8.3.1 Product launches and approvals
        • 15.1.8.3.2 Deals
        • 15.1.8.3.3 Expansions
    • 15.1.9 ASPECT IMAGING LTD.
      • 15.1.9.1 Business overview
      • 15.1.9.2 Products offered
    • 15.1.10 TIME MEDICAL HOLDING
      • 15.1.10.1 Business overview
      • 15.1.10.2 Products offered
      • 15.1.10.3 Recent developments
        • 15.1.10.3.1 Product launches and approvals
        • 15.1.10.3.2 Expansions
    • 15.1.11 NEUSOFT MEDICAL SYSTEMS CO., LTD.
      • 15.1.11.1 Business overview
      • 15.1.11.2 Products offered
      • 15.1.11.3 Recent developments
        • 15.1.11.3.1 Deals
    • 15.1.12 STERNMED GMBH
      • 15.1.12.1 Business overview
      • 15.1.12.2 Products offered
      • 15.1.12.3 Recent developments
        • 15.1.12.3.1 Deals
    • 15.1.13 HYPERFINE, INC.
      • 15.1.13.1 Business overview
      • 15.1.13.2 Products offered
      • 15.1.13.3 Recent developments
        • 15.1.13.3.1 Product launches and approvals
        • 15.1.13.3.2 Deals
    • 15.1.14 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
      • 15.1.14.1 Business overview
      • 15.1.14.2 Products offered
    • 15.1.15 SHENZHEN ANKE HIGH-TECH., LTD.
      • 15.1.15.1 Business overview
      • 15.1.15.2 Products offered
  • 15.2 OTHER PLAYERS
    • 15.2.1 MAGNETICA LTD
    • 15.2.2 AURORA HEALTHCARE US CORP
    • 15.2.3 INNERVISION MRI LTD.
    • 15.2.4 BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.
    • 15.2.5 MEDONICA CO., LTD
    • 15.2.6 NEOSCAN SOLUTIONS GMBH
    • 15.2.7 KANGDA INTERCONTINENTAL MEDICAL EQUIPMENT CO., LTD.
    • 15.2.8 MINFOUND MEDICAL SYSTEMS CO., LTD.
    • 15.2.9 SYNAPTIVE MEDICAL
    • 15.2.10 XINGAOYI MEDICAL EQUIPMENT CO., LTD

16 RESEARCH METHODOLOGY

  • 16.1 RESEARCH DATA
    • 16.1.1 SECONDARY RESEARCH
      • 16.1.1.1 Key secondary sources
      • 16.1.1.2 Key data from secondary sources
      • 16.1.1.3 Objectives of secondary research
    • 16.1.2 PRIMARY RESEARCH
      • 16.1.2.1 Key primary sources
      • 16.1.2.2 Key supply- and demand-side participants
      • 16.1.2.3 Breakdown of primary interviews
      • 16.1.2.4 Objectives of primary research
      • 16.1.2.5 Key primary insights
  • 16.2 MARKET SIZE ESTIMATION
    • 16.2.1 BOTTOM-UP APPROACH
      • 16.2.1.1 Company revenue estimation
      • 16.2.1.2 Customer-based market estimation
      • 16.2.1.3 Primary interviews
    • 16.2.2 TOP-DOWN APPROACH
  • 16.3 GROWTH RATE ASSUMPTIONS
  • 16.4 DATA TRIANGULATION
  • 16.5 RESEARCH ASSUMPTIONS
  • 16.6 RESEARCH LIMITATIONS
  • 16.7 RISK ANALYSIS

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS
Show more
Product Code: MD 3220

List of Tables

  • TABLE 1 MRI SYSTEMS MARKET: UNMET NEEDS
  • TABLE 2 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN THE MRI SYSTEMS MARKET
  • TABLE 3 IMPACT OF PORTER'S FIVE FORCES ON MRI SYSTEMS MARKET
  • TABLE 4 AVERAGE SELLING PRICE OF MRI SYSTEMS, BY KEY PLAYER, 2023-2025
  • TABLE 5 AVERAGE SELLING PRICE OF MRI SYSTEMS, BY REGION, 2023-2025
  • TABLE 6 IMPORT DATA FOR MRI SYSTEMS, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 7 EXPORT DATA FOR MRI SYSTEMS, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 8 MRI SYSTEMS MARKET: LIST OF MAJOR CONFERENCES AND EVENTS IN 2026-2027
  • TABLE 9 CASE STUDY 1: DEPLOYMENT OF WIDE-BORE 3T MRI SYSTEMS TO ENHANCE ONCOLOGICAL DIAGNOSTIC THROUGHPUT IN LARGE TERTIARY HOSPITAL NETWORK
  • TABLE 10 CASE STUDY 2: INTEGRATION OF AI-AUGMENTED 1.5T MRI SYSTEMS IN INDEPENDENT DIAGNOSTIC IMAGING CHAIN TO OPTIMIZE MUSCULOSKELETAL REPORTING EFFICIENCY
  • TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 12 MRI SYSTEMS MARKET: KEY PATENTS, 2024-2026
  • TABLE 13 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 19 NORTH AMERICA: RELEVANT MRI REIMBURSEMENT CODE
  • TABLE 20 EUROPE: RELEVANT MRI REIMBURSEMENT CODE
  • TABLE 21 ASIA PACIFIC: RELEVANT MRI REIMBURSEMENT CODE
  • TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS (%)
  • TABLE 23 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 24 MRI SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 25 BRAIN & NEUROLOGICAL MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 26 SPINE & MUSCULOSKELETAL MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 27 VASCULAR MRI SYSTEMS MARKET, BY REGION, 2024-2031(USD MILLION)
  • TABLE 28 PELVIC & ABDOMINAL MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 29 BREAST MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 30 CARDIAC MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 31 PEDIATRIC MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 32 OTHER APPLICATIONS: MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 33 MRI SYSTEMS MARKET, BY ARCHITECTURE, 2024-2031 (USD MILLION)
  • TABLE 34 CLOSED MRI SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 35 CLOSED MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 36 STANDARD BORE MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 37 WIDE-BORE MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 38 OPEN MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 39 MRI SYSTEMS MARKET, BY DESIGN, 2024-2031 (USD MILLION)
  • TABLE 40 FIXED/STATIONARY MRI SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 41 FIXED/STATIONARY MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 42 FLOOR-FIXED MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 43 CEILING-FIXED MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 44 PORTABLE MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 45 MRI SYSTEMS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 46 MRI SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 47 MRI SYSTEMS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 48 MRI SYSTEMS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 49 MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 50 MRI SYSTEMS MARKET, BY REGION, 2024-2026 (UNITS)
  • TABLE 51 HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 52 1.5T MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 53 3T MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 54 LOW-TO-MID-FIELD MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 55 ULTRA-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 56 MRI SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 57 NORTH AMERICA: MRI SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 NORTH AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 59 NORTH AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2024-2031 (USD MILLION)
  • TABLE 60 NORTH AMERICA: MRI SYSTEMS MARKET, BY DESIGN, 2024-2031 (USD MILLION)
  • TABLE 61 NORTH AMERICA: MRI SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 62 NORTH AMERICA: MRI SYSTEMS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 63 US: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 64 CANADA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 65 EUROPE: MRI SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 66 EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 67 EUROPE: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2024-2031 (USD MILLION)
  • TABLE 68 EUROPE: MRI SYSTEMS MARKET, BY DESIGN, 2024-2031 (USD MILLION)
  • TABLE 69 EUROPE: MRI SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 70 EUROPE: MRI SYSTEMS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 71 GERMANY: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 72 UK: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 73 FRANCE: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 74 ITALY: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 75 SPAIN: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 76 REST OF EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 77 ASIA PACIFIC: MRI SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2024-2031 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: MRI SYSTEMS MARKET, BY DESIGN, 2024-2031 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: MRI SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: MRI SYSTEMS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 83 JAPAN: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 84 CHINA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 85 INDIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 86 AUSTRALIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 87 SOUTH KOREA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 88 REST OF ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 89 LATIN AMERICA: MRI SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 90 LATIN AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 91 LATIN AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2024-2031 (USD MILLION)
  • TABLE 92 LATIN AMERICA: MRI SYSTEMS MARKET, BY DESIGN, 2024-2031 (USD MILLION)
  • TABLE 93 LATIN AMERICA: MRI SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 94 LATIN AMERICA: MRI SYSTEMS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 95 BRAZIL: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 96 MEXICO: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 97 REST OF LATIN AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 98 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 99 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 100 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2024-2031 (USD MILLION)
  • TABLE 101 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY DESIGN, 2024-2031 (USD MILLION)
  • TABLE 102 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 103 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 104 GCC COUNTRIES: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 105 REST OF MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024-2031 (USD MILLION)
  • TABLE 106 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN MRI SYSTEMS MARKET, 2023-2026
  • TABLE 107 MRI SYSTEMS MARKET: DEGREE OF COMPETITION
  • TABLE 108 MRI SYSTEMS MARKET: REGION FOOTPRINT
  • TABLE 109 MRI SYSTEMS MARKET: FIELD STRENGTH FOOTPRINT
  • TABLE 110 MRI SYSTEMS MARKET: APPLICATION FOOTPRINT
  • TABLE 111 MRI SYSTEMS MARKET: END USER FOOTPRINT
  • TABLE 112 MRI SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 113 MRI SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 114 MRI SYSTEMS MARKET: PRODUCT LAUNCHES, JANUARY 2023- MAY 2026
  • TABLE 115 MRI SYSTEMS MARKET: DEALS, JANUARY 2023- MAY 2026
  • TABLE 116 MRI SYSTEMS MARKET: EXPANSIONS, JANUARY 2023- MAY 2026
  • TABLE 117 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 118 SIEMENS HEALTHINEERS: PRODUCTS OFFERED
  • TABLE 119 SIEMENS HEALTHINEERS: PRODUCT LAUNCHES
  • TABLE 120 SIEMENS HEALTHINEERS: DEALS
  • TABLE 121 SIEMENS HEALTHINEERS: EXPANSIONS
  • TABLE 122 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 123 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 124 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
  • TABLE 125 KONINKLIJKE PHILIPS N.V.: DEALS
  • TABLE 126 KONINKLIJKE PHILIPS N.V.: EXPANSIONS
  • TABLE 127 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 128 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 129 GE HEALTHCARE: PRODUCT LAUNCHES
  • TABLE 130 GE HEALTHCARE: DEALS
  • TABLE 131 GE HEALTHCARE: EXPANSIONS
  • TABLE 132 CANON MEDICAL SYSTEMS: COMPANY OVERVIEW
  • TABLE 133 CANON MEDICAL SYSTEMS: PRODUCTS OFFERED
  • TABLE 134 CANON MEDICAL SYSTEMS: PRODUCT LAUNCHES
  • TABLE 135 CANON MEDICAL SYSTEMS: DEALS
  • TABLE 136 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 137 FUJIFILM CORPORATION: PRODUCTS OFFERED
  • TABLE 138 FUJIFILM CORPORATION: PRODUCT LAUNCHES
  • TABLE 139 FUJIFILM CORPORATION: DEALS
  • TABLE 140 FONAR CORPORATION: COMPANY OVERVIEW
  • TABLE 141 FONAR CORPORATION: PRODUCTS OFFERED
  • TABLE 142 FONAR CORPORATION: DEALS
  • TABLE 143 ESAOTE SPA: COMPANY OVERVIEW
  • TABLE 144 ESAOTE SPA: PRODUCTS OFFERED
  • TABLE 145 ESAOTE SPA: PRODUCT LAUNCHES
  • TABLE 146 ESAOTE SPA: DEALS
  • TABLE 147 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW
  • TABLE 148 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCTS OFFERED
  • TABLE 149 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-MAY 2026
  • TABLE 150 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: DEALS, JANUARY 2023-MAY 2026
  • TABLE 151 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: EXPANSIONS
  • TABLE 152 ASPECT IMAGING LTD.: COMPANY OVERVIEW
  • TABLE 153 ASPECT IMAGING LTD.: PRODUCTS OFFERED
  • TABLE 154 TIME MEDICAL HOLDING: COMPANY OVERVIEW
  • TABLE 155 TIME MEDICAL HOLDING: PRODUCTS OFFERED
  • TABLE 156 TIME MEDICAL HOLDING: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-MAY 2026
  • TABLE 157 TIME MEDICAL HOLDING: EXPANSIONS, JANUARY 2023-MAY 2026
  • TABLE 158 NEUSOFT MEDICAL SYSTEMS CO., LTD. : COMPANY OVERVIEW
  • TABLE 159 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED
  • TABLE 160 NEUSOFT MEDICAL SYSTEMS CO., LTD.: DEALS, JANUARY 2023-MAY 2026
  • TABLE 161 STERNMED GMBH: COMPANY OVERVIEW
  • TABLE 162 STERNMED GMBH: PRODUCTS OFFERED
  • TABLE 163 STERNMED GMBH: DEALS, JANUARY 2023-MAY 2026
  • TABLE 164 HYPERFINE, INC.: COMPANY OVERVIEW
  • TABLE 165 HYPERFINE, INC.: PRODUCTS OFFERED
  • TABLE 166 HYPERFINE, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-MAY 2026
  • TABLE 167 HYPERFINE, INC.: DEALS, JANUARY 2023-MAY 2026
  • TABLE 168 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.: COMPANY OVERVIEW
  • TABLE 169 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.: PRODUCTS OFFERED
  • TABLE 170 SHENZHEN ANKE HIGH-TECH., LTD.: COMPANY OVERVIEW
  • TABLE 171 SHENZHEN ANKE HIGH-TECH., LTD: PRODUCTS OFFERED
  • TABLE 172 MAGNETICA LTD: COMPANY OVERVIEW
  • TABLE 173 AURORA HEALTHCARE US CORP: COMPANY OVERVIEW
  • TABLE 174 INNERVISION MRI LTD.: COMPANY OVERVIEW
  • TABLE 175 BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 176 MEDONICA CO., LTD: COMPANY OVERVIEW
  • TABLE 177 NEOSCAN SOLUTIONS GMBH: COMPANY OVERVIEW
  • TABLE 178 KANGDA INTERCONTINENTAL MEDICAL EQUIPMENT CO., LTD.: COMPANY OVERVIEW
  • TABLE 179 MINFOUND MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW
  • TABLE 180 SYNAPTIVE MEDICAL: COMPANY OVERVIEW
  • TABLE 181 XINGAOYI MEDICAL EQUIPMENT CO,. LTD: COMPANY OVERVIEW
  • TABLE 182 MRI SYSTEMS MARKET: RESEARCH ASSUMPTIONS
  • TABLE 183 MRI SYSTEMS MARKET: RISK ANALYSIS

List of Figures

  • FIGURE 1 MARKET SCENARIO
  • FIGURE 2 GLOBAL MRI SYSTEMS MARKET, 2024-2031
  • FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MRI SYSTEMS MARKET, 2024-2025
  • FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF MRI SYSTEMS MARKET
  • FIGURE 5 HIGH-GROWTH SEGMENTS IN MRI SYSTEMS MARKET, 2026-2031
  • FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MRI SYSTEMS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 7 GROWING BURDEN OF CHRONIC AND AGE RELATED DISEASES TO DRIVE MARKET
  • FIGURE 8 CHINA AND JAPAN TO HOLD MAJOR SHARE IN ASIA PACIFIC MARKET IN 2025
  • FIGURE 9 CHINA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031
  • FIGURE 10 MRI SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 11 MRI SYSTEMS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 12 MRI SYSTEMS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 13 MRI SYSTEMS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 14 MRI SYSTEMS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 15 AVERAGE SELLING PRICE TREND OF MRI SYSTEMS, BY KEY PLAYER, 2023-2025 (USD MILLION)
  • FIGURE 16 AVERAGE SELLING PRICE TREND OF MRI SYSTEMS, BY REGION, 2023-2025 (USD MILLION)
  • FIGURE 17 IMPORT SCENARIO FOR MRI SYSTEMS (HS CODE 901813) (USD THOUSAND)
  • FIGURE 18 IMPORT SCENARIO FOR MRI SYSTEMS (HS CODE 901813) (USD THOUSAND)
  • FIGURE 19 MRI SYSTEMS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 20 MRI SYSTEMS MARKET: INVESTMENT AND FUNDING SCENARIO, 2019-2023
  • FIGURE 21 MRI SYSTEMS MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
  • FIGURE 22 MRI SYSTEMS MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 23 PATENTS APPLIED AND GRANTED, 2015-2025
  • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 26 NORTH AMERICA: MRI SYSTEMS MARKET SNAPSHOT
  • FIGURE 27 ASIA PACIFIC: MRI SYSTEMS MARKET SNAPSHOT
  • FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN MRI SYSTEMS MARKET, 2021-2025 (USD MILLION)
  • FIGURE 29 SHARE ANALYSIS OF KEY PLAYERS IN MRI SYSTEMS MARKET, 2025
  • FIGURE 30 RANKING OF KEY PLAYERS IN MRI SYSTEMS MARKET, 2025
  • FIGURE 31 EV/EBITDA OF TOP THREE PLAYERS (2026)
  • FIGURE 32 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF TOP THREE PLAYERS (2026)
  • FIGURE 33 MRI SYSTEMS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 34 MRI SYSTEMS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 35 COMPANY FOOTPRINT
  • FIGURE 36 MRI SYSTEMS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 37 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2025)
  • FIGURE 38 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
  • FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT (2025)
  • FIGURE 40 CANON MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025)
  • FIGURE 41 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 42 FONAR CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 43 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 44 HYPERFINE, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 45 MRI SYSTEMS MARKET: RESEARCH DATA
  • FIGURE 46 MRI SYSTEMS MARKET: RESEARCH DESIGN
  • FIGURE 47 MRI SYSTEMS MARKET: KEY SECONDARY SOURCES
  • FIGURE 48 MRI SYSTEMS MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 49 MRI SYSTEMS MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDES)
  • FIGURE 50 MRI SYSTEMS MARKET: KEY SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 51 MRI SYSTEMS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS (BY COMPANY TYPE, DESIGNATION, AND REGION)
  • FIGURE 52 MRI SYSTEMS MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS
  • FIGURE 53 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 54 MRI SYSTEMS MARKET: COMPANY REVENUE ESTIMATION
  • FIGURE 55 MRI SYSTEMS MARKET: END USER AND REVENUE MAPPING-BASED MARKET SIZE ESTIMATION METHODOLOGY
  • FIGURE 56 MRI SYSTEMS MARKET: TOP-DOWN APPROACH
  • FIGURE 57 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACRO INDICATORS
  • FIGURE 58 MRI SYSTEMS MARKET: DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!